nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Antilymphoma Treatments Given Subsequent to Yttrium 90 Ibritumomab Tiuxetan Are Feasible in Patients with Progressive Non-Hodgkin's Lymphoma: A Review of the Literature
|
Ansell, Stephen M. |
|
2004 |
|
3 |
p. 202-204 3 p. |
artikel |
2 |
An Update of the Epidemiology of Non-Hodgkin's Lymphoma
|
Chiu, Brian C.-H. |
|
2003 |
|
3 |
p. 161-168 8 p. |
artikel |
3 |
A Phase II Study of Heat Shock Protein–PeptideComplex–96 Vaccine Therapy in Patients with Indolent Non-Hodgkin's Lymphoma
|
Younes, Anas |
|
2003 |
|
3 |
p. 183-185 3 p. |
artikel |
4 |
Assessing Immunoglobulin Heavy Chain Rearrangements in Pediatric CD20-Positive and CD20-Negative Classic Hodgkin's Diseas
|
Shiramizu, Bruce |
|
2004 |
|
3 |
p. 184-189 6 p. |
artikel |
5 |
Autologous Peripheral Blood Progenitor Cell Transplantation for Transformed Diffuse Large-Cell Lymphoma
|
Bolwell, Brian |
|
2000 |
|
3 |
p. 226-231 6 p. |
artikel |
6 |
Blastic Natural Killer Cell Leukemia/Lymphoma Presenting as Overt Leukemia
|
Álvarez-Larrán, Alberto |
|
2001 |
|
3 |
p. 178-182 5 p. |
artikel |
7 |
CHOP Chemotherapy with Preemptive Granulocyte Colony-Stimulating Factor in Elderly Patients with Aggressive Non-Hodgkin's Lymphoma: A Dose-Intensity Analysis
|
Jacobson, Joseph O. |
|
2000 |
|
3 |
p. 211-217 7 p. |
artikel |
8 |
CHOP Versus CHOP Plus ESHAP and High-Dose Therapy with Autologous Peripheral Blood Progenitor Cell Transplantation for High-Intermediate–Risk and High-Risk Aggressive Non-Hodgkin's Lymphoma
|
Intragumtornchai, Tanin |
|
2000 |
|
3 |
p. 219-225 7 p. |
artikel |
9 |
Clinical Responses to Sildenafil in Waldenstrom's Macroglobulinemia
|
Treon, Steven P. |
|
2004 |
|
3 |
p. 205-207 3 p. |
artikel |
10 |
Commentary on “Autologous Peripheral Blood Progenitor Cell Transplantation for Transformed Diffuse Large-Cell Lymphoma”
|
Nademanee, Auayporn |
|
2000 |
|
3 |
p. 232-233 2 p. |
artikel |
11 |
Commentary on “Blastic Natural Killer Cell Leukemia/Lymphoma Presenting as Overt Leukemia”
|
Jones, Dan |
|
2001 |
|
3 |
p. 183-184 2 p. |
artikel |
12 |
Commentary on “CHOP Chemotherapy with Preemptive Granulocyte Colony-Stimulating Factor in Elderly Patients with Aggressive Non-Hodgkin's Lymphoma: A Dose-Intensity Analysis”
|
Habermann, Thomas M. |
|
2000 |
|
3 |
p. 218- 1 p. |
artikel |
13 |
Commentary on “Cryofibrinogenemia in a Patient with B-Cell Lymphoma”
|
Siami, Flora S. |
|
2000 |
|
3 |
p. 238-239 2 p. |
artikel |
14 |
Commentary on “Pathologic Diagnosis of Mantle Cell Lymphoma”
|
Pittaluga, Stefania |
|
2000 |
|
3 |
p. 207-208 2 p. |
artikel |
15 |
Commentary on “Rituximab Therapy of B-Cell Neoplasms”
|
Hainsworth, John D. |
|
2000 |
|
3 |
p. 195-196 2 p. |
artikel |
16 |
Cryofibrinogenemia in a Patient with B-Cell Lymphoma
|
Lee, Jo-Ann |
|
2000 |
|
3 |
p. 234-237 4 p. |
artikel |
17 |
Current Status of Recombinant Idiotype Vaccines for the Treatment of Follicular Non-Hodgkin's Lymphoma
|
Maung, Kavita |
|
2002 |
|
3 |
p. 147-149 3 p. |
artikel |
18 |
Current Understanding of Possible Mechanisms of Action and Resistance of Rituximab
|
Fisher, Maxine D. |
|
2001 |
|
3 |
p. 145-147 3 p. |
artikel |
19 |
Denileukin Diftitox and Hyper-CVAD in the Treatment Human T-Cell Lymphotropic Virus 1–Associated Adult T-Cell Leukemia/Lymphoma
|
DiVenuti, Gina |
|
2003 |
|
3 |
p. 176-178 3 p. |
artikel |
20 |
Diffuse Large-Cell Lymphomas: A Review of Therapy
|
Godwin, John E. |
|
2001 |
|
3 |
p. 155-163 9 p. |
artikel |
21 |
Dose-Intense BEACOPP May Be Effective in Patients with Poor Prognostic Hodgkin's Disease
|
|
|
2000 |
|
3 |
p. 181-182 2 p. |
artikel |
22 |
Durable Remission in Recurrent T-Cell—Rich B-Cell Lymphoma with the Anti-CD20 Antibody Rituximab
|
Natkunam, Yasodha |
|
2001 |
|
3 |
p. 185-187 3 p. |
artikel |
23 |
Editorial
|
Jain, Vinay K. |
|
2002 |
|
3 |
p. 137- 1 p. |
artikel |
24 |
Editorial
|
Jain, Vinay K. |
|
2001 |
|
3 |
p. 138- 1 p. |
artikel |
25 |
European Society of Medical Oncology (ESMO), Hamburg, Germany, October 13-17, 2000 American Society of Hematology, San Francisco, CA December 1-5, 2000
|
D'Orazio, Amy I. |
|
2000 |
|
3 |
p. 173-178 6 p. |
artikel |
26 |
Extended Rituximab Therapy for Previously Untreated Patients with Waldenström's Macroglobulinemia
|
Dimopoulos, Meletios A. |
|
2002 |
|
3 |
p. 163-166 4 p. |
artikel |
27 |
Feasibility and Safety of Outpatient Bexxar® Therapy (Tositumomab and Iodine I 131 Tositumomab) for Non-Hodgkin's Lymphoma Based on Radiation Doses to Family Members
|
Rutar, Frank J. |
|
2001 |
|
3 |
p. 164-172 9 p. |
artikel |
28 |
Fludarabine and Cyclophosphamide Combined with Rituximab is a Potent Regimen for Chronic Lymphocytic Leukemia
|
|
|
2000 |
|
3 |
p. 179-180 2 p. |
artikel |
29 |
Gemcitabine-Based Therapy in Relapsed Non-Hodgkin's Lymphoma and Cutaneous T-Cell Lymphoma
|
Lee, David |
|
2003 |
|
3 |
p. 152-153 2 p. |
artikel |
30 |
Gene Expression Profiling as a Diagnostic and Prognostic Tool in B-Cell Non-Hodgkin's Lymphoma
|
Price, Nancy |
|
2003 |
|
3 |
p. 149-151 3 p. |
artikel |
31 |
Hematological Malignancies and Pregnancy: A Final Report of 84 Children Who Received Chemotherapy In Utero
|
Avilés, Agustin |
|
2001 |
|
3 |
p. 173-177 5 p. |
artikel |
32 |
Hemophagocytic Lymphohistiocytosis After Chemotherapy for Multiple Myeloma
|
Terrovitis, John V. |
|
2004 |
|
3 |
p. 194-196 3 p. |
artikel |
33 |
Hepatitis C Infection and B-Cell Non-Hodgkin's Lymphomas
|
Zuckerman, Eli |
|
2002 |
|
3 |
p. 161-162 2 p. |
artikel |
34 |
Hepatitis C Virus Infection and B-Cell Non-Hodgkin's Lymphomas: More Than a Simple Association
|
Musto, Pellegrino |
|
2002 |
|
3 |
p. 150-160 11 p. |
artikel |
35 |
Highlights From: 43rd Annual Meeting of the American Society of Hematology December 7–11, 2001 Orlando, Florida: First International Congress on Monoclonal Antibodies in Cancer August 30-September 2, 2001 Banff, Alberta, Canada
|
D'Orazio, Amy I. |
|
2001 |
|
3 |
p. 139-144 6 p. |
artikel |
36 |
Highlights From: 45th Annual Meeting of the American Society of Hematology December 6-9, 2003 San Diego, California
|
Reddy, Kesava |
|
2003 |
|
3 |
p. 141-148 8 p. |
artikel |
37 |
Highlights From: 46th Annual Meeting of the American Society of Hematology, December 2004, San Diego, California
|
Price, Nancy |
|
2004 |
|
3 |
p. 144-148 5 p. |
artikel |
38 |
Highlights From: VIII International Conference on Malignant Lymphoma June 12–15, 2002 Lugano, Switzerland
|
Lee, David |
|
2002 |
|
3 |
p. 139-144 6 p. |
artikel |
39 |
Lymphomatoid Papulosis from Childhood with Anaplastic Large-Cell Lymphoma of the Small Bowel
|
Perna, Ashley G. |
|
2004 |
|
3 |
p. 190-193 4 p. |
artikel |
40 |
Monoclonal Antibodies in the Prehybridoma Era: A Brief Historical Perspective and Personal Reminiscence
|
Stone, Marvin J. |
|
2001 |
|
3 |
p. 148-154 7 p. |
artikel |
41 |
Monoclonal Immunoglobulins and Peripheral Neuropathy: Causative Agent or Coincidental Finding?
|
Owen, Roger G. |
|
2004 |
|
3 |
p. 172-173 2 p. |
artikel |
42 |
Mood Alterations in Patients Treated with Chlorambucil
|
Hehn, Sean T. |
|
2003 |
|
3 |
p. 179-182 4 p. |
artikel |
43 |
Natural Killer Cell Neoplasms
|
Tse, Eric |
|
2004 |
|
3 |
p. 197-201 5 p. |
artikel |
44 |
Neurologic Complications of Plasma Cell Disorders
|
Drappatz, Jan |
|
2004 |
|
3 |
p. 163-171 9 p. |
artikel |
45 |
Optimizing the Clinical Benefit of Rituximab in Indolent Non-Hodgkin's Lymphoma
|
Gibson, Angelia D. |
|
2004 |
|
3 |
p. 149-151 3 p. |
artikel |
46 |
Pathologic Diagnosis of Mantle Cell Lymphoma
|
Lai, Raymond |
|
2000 |
|
3 |
p. 197-206 10 p. |
artikel |
47 |
Phase II Trial of Remitogen™ (Humanized 1D10) Monoclonal Antibody Targeting Class II in Patients with Relapsed Low-Grade or Follicular Lymphoma
|
Brown, Kevin S. |
|
2001 |
|
3 |
p. 188-190 3 p. |
artikel |
48 |
Phase I Study of Bryostatin-1 and Fludarabine in Patients with Chronic Lymphocytic Leukemia and Indolent Non-Hodgkin's Lymphoma
|
Roberts, John D. |
|
2002 |
|
3 |
p. 184-188 5 p. |
artikel |
49 |
POEMS Syndrome
|
Kyle, Robert A. |
|
2003 |
|
3 |
p. 186- 1 p. |
artikel |
50 |
Primary Adrenal Lymphoma
|
Grigg, Andrew P. |
|
2003 |
|
3 |
p. 154-160 7 p. |
artikel |
51 |
Radioantibodies: Where Do They Fit in?
|
Kaminski, Mark S. |
|
2003 |
|
3 |
p. 137-138 2 p. |
artikel |
52 |
Results of a Phase II Multicenter Trial of Pentostatin and Rituximab in Patients with Low-Grade B-Cell Non-Hodgkin's Lymphoma: An Effective and Minimally Toxic Regimen
|
Drapkin, Robert |
|
2003 |
|
3 |
p. 169-175 7 p. |
artikel |
53 |
Rituximab in Aggressive Non-Hodgkin's Lymphoma: An Update of Studies Presented at the 2004 American Society of Hematology Meeting
|
Gibson, Angelia D. |
|
2004 |
|
3 |
p. 152-154 3 p. |
artikel |
54 |
Rituximab Therapy of B-Cell Neoplasms
|
Petryk, Magdalena |
|
2000 |
|
3 |
p. 186-194 9 p. |
artikel |
55 |
Stage I-IIE Primary Non-Hodgkin's Lymphoma of the Testis: Results of a Prospective Trial by the GOELAMS Study Group
|
Linassier, Claude |
|
2002 |
|
3 |
p. 167-172 6 p. |
artikel |
56 |
Subcutaneous Panniculitis-like T-Cell Lymphoma
|
Wang, Huamin |
|
2002 |
|
3 |
p. 181-183 3 p. |
artikel |
57 |
Subcutaneous Panniculitis-like T-Cell Lymphoma: Presentation of 2 Cases and Observations
|
Papenfuss, Jason S. |
|
2002 |
|
3 |
p. 175-180 6 p. |
artikel |
58 |
Testicular Lymphoma: A Mysterious Link Between the Testis and the Brain
|
Wang, Michael L. |
|
2002 |
|
3 |
p. 173-174 2 p. |
artikel |
59 |
Treatment Options in Waldenstrom's Macroglobulinemia
|
Björkholm, Magnus |
|
2004 |
|
3 |
p. 155-162 8 p. |
artikel |
60 |
Trials in Advanced Hodgkin's Disease: More than 30 Years Experience of the British National Lymphoma Investigation
|
Zekri, Jamal M. |
|
2004 |
|
3 |
p. 174-183 10 p. |
artikel |